Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion type Assertion NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_head.
- NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion description "[Seventeen sustained virologic responders showed lower pretreatment hepatitis C virus (HCV)-RNA levels (P = 0.017) in serum and higher pretreatment levels of IFNAR2 mRNA in liver (P = 0.007), but not in PBMCs, compared with nonsustained virologic responders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_provenance.
- NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion evidence source_evidence_literature NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_provenance.
- NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion SIO_000772 14996348 NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_provenance.
- NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion wasDerivedFrom befree-20140225 NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_provenance.
- NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_assertion wasGeneratedBy ECO_0000203 NP413150.RAxuR3DfF5Bf_ilGsdryOd7FtIgsL98ZdTTduzorXw6bk130_provenance.